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Abstract
Purpose: To identify non-invasive clinical parameters to predict urodynamic bladder outlet obstruction (BOO) in patients
with benign prostatic hyperplasia (BPH) using causal Bayesian networks (CBN).
Subjects and Methods: From October 2004 to August 2013, 1,381 eligible BPH patients with complete data were selected
for analysis. The following clinical variables were considered: age, total prostate volume (TPV), transition zone volume (TZV),
prostate specific antigen (PSA), maximum flow rate (Qmax), and post-void residual volume (PVR) on uroflowmetry, and
International Prostate Symptom Score (IPSS). Among these variables, the independent predictors of BOO were selected
using the CBN model. The predictive performance of the CBN model using the selected variables was verified through a
logistic regression (LR) model with the same dataset.
Results: Mean age, TPV, and IPSS were 6.2 (67.3, SD) years, 48.5 (625.9) ml, and 17.9 (67.9), respectively. The mean BOO
index was 35.1 (625.2) and 477 patients (34.5%) had urodynamic BOO (BOO index $40). By using the CBN model, we
identified TPV, Qmax, and PVR as independent predictors of BOO. With these three variables, the BOO prediction accuracy
was 73.5%. The LR model showed a similar accuracy (77.0%). However, the area under the receiver operating characteristic
curve of the CBN model was statistically smaller than that of the LR model (0.772 vs. 0.798, p = 0.020).
Conclusions: Our study demonstrated that TPV, Qmax, and PVR are independent predictors of urodynamic BOO.
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Introduction
Urodynamic study (UDS) is considered the gold standard for
clinical assessment of bladder outlet obstruction (BOO) in patients
with benign prostatic hyperplasia (BPH) [1]. Patients with
urodynamic BOO show higher efficacy after transurethral surgery
[2]. In this respect, BOO is helpful in stratifying BPH patients
eligible for surgical treatment. However, UDS has significant
limitations in terms of invasiveness, cost, and morbidity [3].
Numerous attempts have been made to substitute non-invasive
clinical parameters for UDS to predict BOO; however, individual
variables, including symptom score [4], prostate specific antigen
(PSA) level [5], free uroflowmetry (UFM) [6], post-void residual
(PVR) urine volume [7], and prostate size [8], have shown a poor
to weak correlation with BOO.
To improve prediction ability, combinations of non-invasive
clinical parameters have been investigated to predict BOO [9–17].
The statistical methods used for combinations were diverse from
the cumulative scoring system [9], to the construction of a formula
by logistic regression analysis [10–13], to the artificial neural
network (ANN) models [14–17]. However, these attempts had
limited predictive performance. Moreover, the need to use
numerous clinical parameters makes clinical application difficult.
Furthermore, some predictive models [14–17] could not explain
which variables are comparatively important for BOO owing to
their ‘black box’ nature [18].
Causal Bayesian networks (CBN) have emerged as an advanced
alternative to conventional statistical models in the medical field
[19]. The benefit of this model is that it can visualize the
interaction of causes and rule out indirect causes of events [20].
Hence, we aimed to identify non-invasive clinical parameters to
predict BOO using a CBN model. To the best of our knowledge,
this study is the first to test CBN model for BOO prediction.
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Materials and Methods
I. Data collection
The Institutional Review Board of Seoul National University
Hospital (SNUH) approved the protocol of this study. A database
of 2,492 patients that were older than 45 and that had lower
urinary tract symptoms (LUTS) was created from records dated
between October 2004 and August 2013. The data were retrieved
from the urodynamic database registry and Electronic Medical
Records System of SNUH. All information was anonymised and
de-identified prior to analysis. Patients with a history of previous
genitourinary surgery, pelvic radiation therapy, urinary tract
infection, urethral stricture, interstitial cystitis, and neuropathy
suggesting neurogenic bladder or incomplete evaluations were
excluded. Thus, after excluding 1,111 such patients (44.6%), the
data from 1,381 patients were analyzed.
Clinical parameters of the subjects, including history, physical
examination, International Prostatic Symptom Score (IPSS) [21],
UFM, PVR, PSA, prostate volume (PV) measured by transrectal
ultrasonography, and UDS results were retrieved. UFM (Flow-
master, Medical Measurement System, Enschede, Netherlands)
results were obtained as free flow, whenever voided volume was
less than 120 ml, and fails were repeated. PVR was measured after
UFM using an ultrasound bladder scanner (BladderScan BVI
3000, Verathon Inc., WA, USA). All UDS were performed using a
multichannel video system (UD-2000, Medical Measurement
System) according to International Continence Society (ICS)
recommendations [22]. The BOO index, which is equal to
detrusor pressure at maximal flow rate (PdetQmax)226maximal
flow rate (Qmax), was used to determine BOO [23]. Patients with
BOO Index $40 were considered as obstructed.
II. Database characteristics
The patient demographics characteristics are shown in Table 1.
The mean age of patients was 66.2 (67.3, SD) years. The TPV
and PSA were 48.5 (625.9) ml and 2.71 (63.53) ng/ml,
respectively. The IPSS-total, IPSS-storage, IPSS-emptying, and
IPSS-QoL were 17.9 (67.9), 7.1 (63.5), 10.8 (65.5), and 3.9
(61.2), respectively. The Mean BOO index was 35.1 (625.2), and
477 patients (34.5%) were classified as having BOO.
III. Statistical methods for BOO prediction
To predict BOO, the following two statistical methods were
applied.
1) Logistic regression (LR) analysis. A backward stepwise
regression analysis [24] was utilized. Age, total prostate
volume (TPV), transition zone volume (TZV), PSA, Qmax,
PVR and IPSS were entered into LR model as variables for
BOO prediction. Relative risk (Exp(b)) of BOO was
calculated, with each non-invasive parameter increasing by
one unit.
2) Causal Bayesian networks (CBN). If event A causes
events B and C, and these events directly influence event D,
the probability of event D depends on each of the possible
values of events B and C. The probability of event D can be
expressed in the equation, P (event D| event B, event C). In
Table 1. Characteristics of 1,381 patients.
Total subjects (N=1381)
Age (years) 66.267.3
Prostate volume (ml)
Total prostate volume 48.5625.9
Transitional zone volume 24.1622.4
Prostate specific antigen (ng/ml) 2.7163.53
International Prostatic Symptom Score (IPSS)
IPSS-total 17.967.9
IPSS-storage 7.163.5
IPSS-emptying 10.865.5
IPSS-quality of life 3.961.2
Uroflowmetry parameters
Maximum flow rate (ml/sec) 11.664.9
Post-void residual volume (ml) 58.1677.8
Urodynamic study parameters
Maximal urethral closure pressure (cmH2O) 74.3626.8
Functional urethral length (mm) 72.0620.6
First desire (ml) 203.0690.1
Normal desire (ml) 284.96108.2
Strong desire (ml) 371.76108.3
Compliance (ml/cmH2O) 67.3650.8
PdetQmax (cmH2O) 52.6621.7
Opening pressure (cmH2O) 54.3625.8
Bladder outlet obstruction index 35.1625.2
PdetQmax, detrusor pressure at maximum flow rate.
doi:10.1371/journal.pone.0113131.t001
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that case, events A and D are in the causal Markov condition
[25]. This means that event A is not a direct cause of event D.
If the probabilities of direct causes (events B and C) are
conditioned, event A does not influence the probability of
event D. The causal Markov condition can be visually
identified in a CBN, which has a relationship of two or more
degrees between nodes. Considering that events A and D have
a two degree relationship, we can easily infer that these two
events are conditionally independent.
The causal Markov condition permits the joint distribution of
the n variables in a CBN to be factored as in the following
equation:
P(x1,x2,:::,xnDK)~P
n
i~1
P(xi Dpi,K)
where xi denotes a state of variable Xi, pi denotes a joint state of
the parents of Xi, and K denotes background knowledge [20].
IV. Identification and verification of the independent
parameters
CBN was applied to identify the independent predictors of
BOO. The causal relationships and their interactions were
visualized by established CBN. The variables only directly linked
to BOO were selected as the independent predictors. The weights
of each selected variable were estimated using the Spearman’s
correlation test. The accuracy of BOO prediction model using the
selected variables was compared with that of the LR model. To
compare the predictive performance, the comparison of receiver
operating characteristic (ROC) curves by DeLong et al. [26] was
applied.
A p-value ,0.05 was considered significant. A CBN model to
predict BOO was established using the Banjo version 2.2.0
software (Duke University, Durham, NC, USA; non-commercially
available at: http://www.cs.duke.edu/,amink/software/banjo/).
Highlights of the settings are limiting the number of parents to five
and running the analysis for up to 6 hours (the Banjo setup file is
presented in Appendix S1). The commercial statistical program
package SPSS version 18.0 (Chicago, IL, USA) was used for LR,
Spearman correlation, and other descriptive statistical analyses.
MedCalc version 12.4.0 (Ostend, Belgium) was applied for the
comparison of ROC curves.
Results
Identification of non-invasive BOO predictors using CBN
Based on the BPH patient data, the best network structure was
selected/learned using the CBN model (Fig. 1). TPV, Qmax, and
PVR exhibited direct relationships with BOO. Therefore, those
three variables were selected as non-invasive independent predic-
Figure 1. Causal Bayesian network model for bladder outlet obstruction. TPV, total prostate volume; TZV, transitional zone volume; PSA,
prostatic specific antigen; BOO, bladder outlet obstruction; Qmax, maximum flow rate; PVR, post-void residual volume; IPSS, International Prostate
Symptom Score.
doi:10.1371/journal.pone.0113131.g001
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tors of BOO. The correlation coefficient was the highest for TPV
(R=0.391 p,0.001), followed by Qmax (R=20.253, p,0.001)
and PVR (R=0.214, p,0.001).
Verification of BOO prediction
Sensitivity, specificity, and accuracy of BOO predictions with
the aforementioned three variables by CBN were 51.4%, 85.2%,
and 73.5%, respectively (Table 2). In the LR model, age
(Exp(b) = 0.981, p = 0.046), Qmax (Exp(b) = 0.890, p,0.001),
PVR (Exp(b) = 1.003, p,0.001), TPV (Exp(b) = 1.014, p =
0.049), TZV (Exp(b) = 1.039, p,0.001), PSA (Exp(b) = 1.051,
p = 0.039) IPSS item 2 (frequency) (Exp(b) = 0.866, p = 0.007), and
IPSS item 4 (Urgency) (Exp(b) = 1.227, p,0.001) were selected as
significant predictive variables. In the LR model, the sensitivity,
specificity, and accuracy were 51.6%, 90.4%, and 77.0%,
respectively.
To compare the predictive power of the three selected non-
invasive clinical parameters, a comparison of ROC curves was
performed. The area under ROC curve (AUROC) of CBN and
the LR models were 0.772 and 0.798, respectively (p = 0.020;
figures not presented).
Discussion
Because individual variables have a very low correlation with
BOO, many researchers have built statistical prediction methods
that combine multiple variables [9–13]. For this purpose, they
have used diverse variables, including Qmax, PVR, IPSS, PSA,
and PV. However, no one has established a specific independent
predictor of BOO [9–13]. Some differences in detailed variables
have been suggested for prediction models. Moreover, the number
of variables used in these predictions is too many to be feasible for
real-life practice with BPH patients.
Previous studies seeking to identify non-invasive predictors of
BOO have encountered two major difficulties. The first is the non-
linear relationship between the variables. Among the single non-
processed variables, prostate size seems to be one of the most
highly correlating variables with BOO (R range: 0.28–0.32, p,
0.001) [8,27]. However, Eckhardt et al. [27] have found that mean
TPV decreased at the Scha¨fer grade of 5 and 6, contrary to
general expectations. These non-linear conditions occur common-
ly in clinical medicine. The second difficulty stems from the fact
that some clinical parameters have a co-variability, fiu., some
clinical parameters interact with each other [19], so that the
established model is capable of overestimating or underestimating
the predictive power. Bell et al. [28] reported that increased PVR
occurs in BOO patients. However, Eckhard et al. [27] pointed out
that larger PVR may reflect detrusor underactivity rather than
BOO. Yet, Kranse et al. [7] supported the findings that BOO and
detrusor underactivity commonly cause a higher PVR.
ANN models are expected to be able to detect non-linear
relationships and interactions between predictor variables. Sonke
et al. [14] proposed the first ANN model for BOO prediction
using 1903 patients. IPSS, Qmax, PVR, TPV, and PSA were used
as the input variables. They reported that overall sensitivity and
specificity were 71% and 69%. Wadie et al. [15] reported the
higher predictive power of ANN compared to conventional
statistical models among 460 subjects using only IPSS. However,
the same group presented another ANN model considering
average flow rate and Qmax on UFM, PVR, and TPV in variable
conditions and showing only moderate performance with 76%
accuracy [17]. Another study reported 82% and 77% sensitivity
and specificity, respectively, using IPSS, TPV, PSA, and UFM
results [16]. Comprehensive results show, however, that the
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predictive performance of ANN is not superior to that of the
conventional linear models. Moreover, due to the ‘black box’
nature of ANN, the model cannot be easily interpreted [18].
Therefore, these models do not explain the relative contribution of
non-invasive clinical parameters to urodynamic BOO.
In general, the advantage of CBNs is that they can identify
conditional independence relationships and thus make it possible
to confirm the only direct independent causes of the events. We
expected that this advantage of the CBN model could confirm
independent variables for the prediction of BOO. In this study,
through the established CBN model, we found that TPV, Qmax,
and PVR were important predictors of BOO (Fig. 1). Our BOO
prediction model with only three independent variables (TPV,
Qmax, and PVR) showed moderate predictive value (Table 2)
To compare the performance of the BOO prediction model
using the three selected independent predictors, the LR model was
established from the same dataset and the predictive powers of the
two models were compared (Table 2). The LR model showed a
predictive performance comparable with that reported in previous
studies [10–13]. The predictive performance of the CBN model
was statistically inferior to that of the LR model (AUROC: 0.772
vs. 0.798; p = 0.020). However, when only the three variables
(TPV, Qmax, and PVR) were taken into account to predict BOO,
the accuracy was not overly compromised compared with when
using the complex equations (considering age, Qmax, PVR, TPV,
TZV, PSA, IPSS item 2, and item 4 as predictive variables), which
were derived from the LR model. These three non-invasive
clinical parameters are also routinely evaluated in actual clinical
practice for BPH patients.
Indeed, our CBN model comprised categorized values of
clinical parameters due to in nature characteristics of CBN model
for clarifying interactions between the variables. It is not clear
whether the lower performance of CBN originates from the
elliptical non-invasive clinical parameters or from transforming the
clinical parameters into categorical variables to estimate the CBN
models. However, it is interesting that the BOO can be predicted
moderately with only three non-invasive clinical parameters. This
study was unable to conclude whether the other variables that
show conditional independence can be excluded for BOO
prediction.
Our data showed that TPV was the most important predictive
factor for BOO (R=0.391), followed by, Qmax (R=20.253), and
PVR (0.214) in that order. Our results are consistent with those of
previous studies which reported that TPV had a higher correlation
with BOO compared to the other non-invasive clinical parameters
[10–13]. These results suggest that TPV is the most important
clinical parameter for BOO prediction in real clinical practice and
that TZV and PSA do not need to be considered as predictors.
Qmax and PVR also had a moderate correlation with
BOO(|R| range: 0.214–0.253). CBN showed that these variables
are independent predictors of BOO. Therefore, these clinical
parameters should be considered in BOO prediction. Previous
studies considered various combinations of UFM results, such as
Qmax, average flow rate (Qavg), and PVR in prediction models
[9–13], but it has not yet been concluded which variables are the
more important predictors of BOO. Our CBN model showed that
Qmax and PVR are important for BOO prediction.
It is interesting that all IPSS items showed conditional
independence (not independent predictors) for BOO prediction
(Fig. 1). Previous studies excluded the IPSS from the BOO
prediction model [10–13], and van Venrooij et al. [4] reported
that IPSS has no statistical correlation with urodynamic obstruc-
tion grade; these are in agreement with our CBN results. However,
in our LR model IPSS item 2 (frequency) and IPSS item 4
(urgency) were predictors of BOO (p range: ,0.001 to 0.007).
The strength of this study is that we made our non-missing
dataset of 1,381 patients large enough to support the construction
of the CBN model. Moreover, in our study, all of the UDS were
performed uniformly using the same protocol following ICS
recommendations [22]. However, our current study has some
limitations. Our model was unable to account for the weight of
each independent predictor. Therefore, the relative importance of
predictors should be identified by means of indirect correlation
analysis. Second, our CBN model is built from a cross-sectional
database; hence, in a strict sense, our model did not show cause-
effect relationships between parameters, but showed simple
correlations or interactions. It is thus impossible to confirm
variables that precede the cause. Finally, the predictive power of
CBN model was too low for the model to be considered to be
useful in clinical practice. We believe that additional well-designed
and in-depth researches into the CBN model are needed.
Conclusions
Our results show that TPV, Qmax, and PVR are independent
non-invasive predictors of BOO. Among them, TPV is the most
important clinical parameter for predict of BOO.
Supporting Information
Appendix S1 Banjo setting file used for causal Bayesian
network model of this study.
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